Literature DB >> 22555318

Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?

Harald Hefter1, Wolfgang H Jost, Andrea Reissig, Benjamin Zakine, Abdel Magid Bakheit, Jörg Wissel.   

Abstract

A significant percentage of patients suffering from a stroke involving motor-relevant central nervous system regions will develop a spastic movement disorder. Hyperactivity of different muscle combinations forces the limbs affected into abnormal postures or movement patterns. As muscular hyperactivity can effectively and safely be treated with botulinum toxin type A (BoNT-A), we present a classification of spastic arm movement patterns to support BoNT-A therapy of arm spasticity. A few characteristic patterns can be distinguished that may be relevant for BoNT-A treatment. On the basis of a differentiated posture and arm movement analysis, five characteristic arm spasticity patterns (ASP I-V) were defined with respect to the position of the shoulder, elbow, forearm, and wrist joints. These patterns were verified using data from a worldwide noninterventional Upper Limb International Survey. By clinical observation, spastic arm postures in 94% of 665 poststroke patients could be assigned to one of these five ASPs. The most frequent pattern of arm spasticity was ASP III (41.8%) with internal rotation and adduction of the shoulder and flexion at the elbow coupled with a neutral positioning of the forearm and wrist, not the typical Wernicke-Mann position. These five different arm position patterns (ASP I-V) form the foundation of a common terminology and facilitate quick and understandable exchange of information with other physicians. Furthermore, utilization of these patterns may improve the dosing, goal setting, and outcome of the BoNT-A treatment of arm spasticity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555318     DOI: 10.1097/MRR.0b013e328353e3d4

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  14 in total

1.  Effect of kinesiotaping on pain relief and upper limb function in stroke survivors: a systematic review and meta-analysis.

Authors:  Botao Tan; Gongwei Jia; Yunling Song; Wei Jiang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 2.  Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity.

Authors:  Khashayar Dashtipour; Jack J Chen; Heather W Walker; Michael Y Lee
Journal:  Am J Phys Med Rehabil       Date:  2015-03       Impact factor: 2.159

3.  The Use of Functional Electrical Stimulation on the Upper Limb and Interscapular Muscles of Patients with Stroke for the Improvement of Reaching Movements: A Feasibility Study.

Authors:  Alicia Cuesta-Gómez; Francisco Molina-Rueda; Maria Carratala-Tejada; Eukene Imatz-Ojanguren; Diego Torricelli; Juan Carlos Miangolarra-Page
Journal:  Front Neurol       Date:  2017-05-10       Impact factor: 4.003

4.  Treatment diary for botulinum toxin spasticity treatment: a pilot study.

Authors:  Bo Biering-Sørensen; Helle K Iversen; Inge M S Frederiksen; Jeanet R Vilhelmsen; Fin Biering-Sørensen
Journal:  Int J Rehabil Res       Date:  2017-06       Impact factor: 1.479

5.  "Appropriate Treatment" and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units.

Authors:  Giancarlo Ianieri; Riccardo Marvulli; Giulia Alessia Gallo; Pietro Fiore; Marisa Megna
Journal:  Toxins (Basel)       Date:  2018-03-28       Impact factor: 4.546

6.  Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.

Authors:  Tiina Rekand; Bo Biering-Sörensen; Jun He; Ole Jakob Vilholm; Peter Brøgger Christensen; Trandur Ulfarsson; Roger Belusa; Torbjörn Ström; Peter Myrenfors; Pascal Maisonobe; Torben Dalager
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

7.  Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.

Authors:  Xu Yan; Jie Lan; Yancheng Liu; Jun Miao
Journal:  Med Sci Monit       Date:  2018-11-13

8.  Protective Effects of MiR-129-5p on Acute Spinal Cord Injury Rats.

Authors:  Ruifeng Yang; Xiaobin Cai; Jian Li; Feng Liu; Tao Sun
Journal:  Med Sci Monit       Date:  2019-11-04

9.  The nature and extent of upper limb associated reactions during walking in people with acquired brain injury.

Authors:  Michelle B Kahn; Ross A Clark; Gavin Williams; Kelly J Bower; Megan Banky; John Olver; Benjamin F Mentiplay
Journal:  J Neuroeng Rehabil       Date:  2019-12-27       Impact factor: 4.262

10.  Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop.

Authors:  Harald Hefter; Werner Nickels; Dietmar Rosenthal; Sara Samadzadeh; Philipp Albrecht
Journal:  Toxins (Basel)       Date:  2021-07-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.